Donald R. Sullivan, MD, MA, MCR; Benjamin Chan, MS; Jodi A. Lapidus, PhD; et al.
free access
JAMA Oncol. 2019;5(12):1702-1709. doi:10.1001/jamaoncol.2019.3105
This retrospective cohort study assesses whether the receipt of early palliative care is associated with a survival benefit among patients with advanced lung cancer receiving care in the Veterans Affairs health care system.
-
Editorial
Prolonged Survival With Palliative Care鈥擨t Is Possible, but Is It Necessary?
Ryan Nipp, MD; Areej El-Jawahri, MD; Jennifer Temel, MD
JAMA Oncol
Jeanne Tie, MD; Joshua D. Cohen, BS; Yuxuan Wang, PhD; et al.
free access
JAMA Oncol. 2019;5(12):1710-1717. doi:10.1001/jamaoncol.2019.3616
This multicenter cohort study assesses whether serial postsurgical and postchemotherapy analyses of circulating tumor DNA levels could provide a real-time indication of adjuvant therapy efficacy in patients with stage III colon cancer.
-
Editorial
Is the Patient Cured?
Harry B. Burke, MD, PhD; Scott Kopetz, MD, PhD
JAMA Oncol
Li Sun, MSc; Adam Brentnall, PhD; Shreeya Patel, MSc; et al.
open access
has audio
JAMA Oncol. 2019;5(12):1718-1730. doi:10.1001/jamaoncol.2019.3323
This cost-effectiveness microsimulation modeling study estimates incremental lifetime effects, costs, and cost-effectiveness of multigene testing of all patients with breast cancer compared with selective testing based on family history or clinical criteria.
-
Podcast:
Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer
-
Podcast:
Testing for Breast Cancer Susceptibility Genes
Joyce F. Liu, MD, MPH; Christina Herold, MD; Kathryn P. Gray, PhD; et al.
free access
JAMA Oncol. 2019;5(12):1731-1738. doi:10.1001/jamaoncol.2019.3343
This phase 2 clinical trial examines the use of nivolumab combined with bevacizumab in treatment of women with relapsed platinum-sensitive or platinum-resistant ovarian cancer.
Nico Gagelmann; Andrea Bacigalupo, MD; Alessandro Rambaldi, MD; et al.
free access
JAMA Oncol. 2019;5(12):1739-1748. doi:10.1001/jamaoncol.2019.3541
This systematic review and meta-analysis assesses outcomes of stem cell transplantations using the haploidentical stem cell transplantation with posttransplant cyclophosphamide therapy compared with other mismatched or matched donor transplants in adult patients with hematologic cancers.
Global Burden of Disease Cancer Collaboration
open access
JAMA Oncol. 2019;5(12):1749-1768. doi:10.1001/jamaoncol.2019.2996
This systematic analysis describes cancer burden for 29 cancer groups across 195 countries from 1990 through 2017 to provide data needed for cancer control planning.